When given the power to choose:
Nearly 70% of people reported that they would choose quarterly dosing instead of monthly dosing.1*
DOSING FOR AJOVY*253 chronic and episodic migraine patients who previously participated in clinical trials were recruited to complete an online survey. Patients, blinded as to whether they received monthly or quarterly injections of AJOVY, were asked, “Would you rather take the injectable migraine medicine as 1 injection once a month or 3 injections once every 3 months?” 69% of respondents said they’d rather take the quarterly dosing option and 31% said they’d rather take the monthly dosing option.1
